Venostent Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Venostent co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Venostent Co Today - Breaking & Trending Today

VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial ....

United States , Geoffrey Lucks , Eric Peden , Hala Barakat , Jenniferl Horspool , Timothy Boire , Jason Burgess , Tim Boire , Venostent Selfwrap Bioabsorbable Perivascular , Mark Barakat , Clinical Affairs Mark Barakat , News Network , Clinical Affairs , Venostent Inc , National Science Foundation , Breakthrough Technology , National Principal Investigator , National Institute Of Health , Venostent Co , Stent Enrolls First Subjects , Fistulas Clinical Trial , Surgical Specialists , Vascular Surgeons , Selfwrap Bioabsorbable Perivascular Wrap , Venostent Director , Project Coordinator Hala Barakat ,

VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients

VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients
Share Article
Creative Ventures leads the funding round, with participation from IAG Capital Partners
While we are laser-focused on our first indication, hemodialysis access, what’s additionally so exciting is that this approach avails to us a whole host of potential applications in ‘perivascular wrapping,’ said Geoff Lucks, VenoStent’s Co-Founder and COO.
NASHVILLE, Tenn. (PRWEB)
February 23, 2021
VenoStent, a Houston-based advanced materials company, today announced $2.3M in seed funding. The company leverages its unique polymer engineering technology to develop bioresorbable slip-on polymer wraps, called SelfWrap. The product is aimed to eliminate vascular surgery failures, at first targeting vascular access surgery required to initiate hemodialysis treatment for end-stage ren ....

United States , Alex Luce , Kulika Weizman , Geoff Lucks , Tim Boire , Texas Halo Fund , Venostent Co , Human Services , National Institutes Of Health , Sp Investment Fund , National Science Foundation , Health Wildcatters , Venostent Inc , Centers For Medicare , Department Of Health , American Society Of Nephrology , Medicaid Services , Olima Ventures , Cowtown Angels , National Institutes , Dialysis Phase , American Society , Activated Capital , Cougar Ventures , Breakthrough Device Designation , Investigational Device Exemption ,